<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="219311">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00229216</url>
  </required_header>
  <id_info>
    <org_study_id>T-500</org_study_id>
    <nct_id>NCT00229216</nct_id>
  </id_info>
  <brief_title>Treatment of Bacterial Vaginosis With Oral Tinidazole</brief_title>
  <official_title>A Phase III Randomized, Multi-center, Double-blind, Double-dummy, Placebo-controlled Treatment Trial of Bacterial Vaginosis With Tinidazole Oral Tablets.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mission Pharmacal</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mission Pharmacal</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to confirm the safety and efficacy of oral tinidazole for the
      treatment of bacterial vaginosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Tinidazole is a second-generation nitroimidazole i.e. an updated form of the standard drug
      used to treat bacterial vaginosis (metronidazole). Two dosing regimens are being compared to
      placebo to treat bacterial vaginosis, one of the most common vaginal infections.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2005</start_date>
  <completion_date type="Actual">June 2007</completion_date>
  <primary_completion_date type="Actual">June 2007</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (masked roles unspecified)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Therapeutic efficacy</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical efficacy</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Microbiological efficacy</measure>
  </secondary_outcome>
  <enrollment type="Actual">200</enrollment>
  <condition>Bacterial Vaginosis</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tinidazole</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Clinical and microbiological diagnosis of bacterial vaginosis -

        Exclusion Criteria:

        Other sexually transmitted disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Duke University School of Medicine</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 21, 2017</lastchanged_date>
  <firstreceived_date>September 27, 2005</firstreceived_date>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vaginal Diseases</mesh_term>
    <mesh_term>Vaginosis, Bacterial</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Tinidazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
